Previous studies have shown that breast cancer cells contain stem-cell-like cells that express CD44+CD24-/low marker, and compared to non-CD44+CD24-/low cancer cells, these cells possess more than 50-fold increased tumorigenic capacity. This evidence concerns the gene CD44 and breast carcinoma.